(2018-) Reference: CB17/08/00004. Funded by MINECO – Instituto de Salud Carlos III. P.I. Jorge Bondia. Co-PI. Josep Vehí. Other researchers: Remei Calm. Coordinated project (UdG, UPV, Hospital Clínico Universitario de Valencia, Hospital Francesc de Borja de Gandia).
Research will be conducted on artificial pancreas and related technologies, such as continuous glucose monitoring and automatic patient monitoring using artificial intelligence techniques.
The development and validation of new artificial pancreas systems to improve the efficiency and safety of food intake and exercise is proposed as a general objective. The complexity of the glycemic effect of intakes and exercise suggests the need for more degrees of freedom than current systems based solely on the measurement of glucose and insulin infusion. The use of additional signals to glucose, for example from physical activity monitors, to measure or estimate such disturbances and facilitate the automatic monitoring of the patient with the characterization of glycemic patterns and risk situations, as well as the incorporation of new counterregulatory actuation signals for greater safety in the face of hypoglycaemia, especially in the case of exercise, can be fundamental in overcoming the limitations of current systems in a second generation of artificial pancreas. This gives rise, in terms of control engineering, to new multivariable architectures of the artificial pancreas.
The annual organization of a Multidisciplinary Workshop on New Technologies for Diabetes is proposed. This is intended to establish a scientific-technological and innovation forum for interaction between clinical teams, engineering teams and industry, in various areas related to new technologies applied to diabetes, which catalyzes multidisciplinary research in the area and transfer activities, strengthening the various groups of CIBERDEM.